Jiujiang Defu Technology Co., Limited

SZSE:301511 Stock Report

Market Cap: CN¥8.9b

Jiujiang Defu Technology Balance Sheet Health

Financial Health criteria checks 1/6

Jiujiang Defu Technology has a total shareholder equity of CN¥4.6B and total debt of CN¥8.3B, which brings its debt-to-equity ratio to 179.7%. Its total assets and total liabilities are CN¥16.1B and CN¥11.4B respectively.

Key information

179.7%

Debt to equity ratio

CN¥8.33b

Debt

Interest coverage ration/a
CashCN¥4.32b
EquityCN¥4.64b
Total liabilitiesCN¥11.43b
Total assetsCN¥16.06b

Recent financial health updates

Recent updates

Jiujiang Defu Technology (SZSE:301511) Is Carrying A Fair Bit Of Debt

Dec 16
Jiujiang Defu Technology (SZSE:301511) Is Carrying A Fair Bit Of Debt

Jiujiang Defu Technology Co., Limited (SZSE:301511) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Nov 11
Jiujiang Defu Technology Co., Limited (SZSE:301511) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Is Jiujiang Defu Technology (SZSE:301511) A Risky Investment?

Aug 10
Is Jiujiang Defu Technology (SZSE:301511) A Risky Investment?

Shaky Earnings May Not Tell The Whole Story For Jiujiang Defu Technology (SZSE:301511)

Apr 25
Shaky Earnings May Not Tell The Whole Story For Jiujiang Defu Technology (SZSE:301511)

Is Jiujiang Defu Technology (SZSE:301511) A Risky Investment?

Apr 21
Is Jiujiang Defu Technology (SZSE:301511) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: 301511's short term assets (CN¥9.7B) do not cover its short term liabilities (CN¥10.0B).

Long Term Liabilities: 301511's short term assets (CN¥9.7B) exceed its long term liabilities (CN¥1.5B).


Debt to Equity History and Analysis

Debt Level: 301511's net debt to equity ratio (86.6%) is considered high.

Reducing Debt: 301511's debt to equity ratio has increased from 103% to 179.7% over the past 5 years.

Debt Coverage: 301511's debt is not well covered by operating cash flow (3.5%).

Interest Coverage: Insufficient data to determine if 301511's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies